Living Donor Lung Transplantation for Pleuroparenchymal Fibroelastosis

Ann Thorac Surg. 2016 May;101(5):1970-2. doi: 10.1016/j.athoracsur.2015.07.056.

Abstract

We report the first patient with pleuroparenchymal fibroelastosis (PPFE) to undergo living donor bilateral lobar lung transplantation. The patient was diagnosed with secondary PPFE as a late complication of chemotherapy that included high-dose cyclophosphamide for mature B-cell lymphocytic leukemia. Although the patient maintained complete remission, dry cough and back pain appeared 8 years after the chemotherapy. He had repeated bilateral pneumothoraces, and his respiratory condition gradually deteriorated because of progressive pleural thickening and parenchymal fibrosis. He underwent living-donor bilateral lobar lung transplantation with an inverse transplant on the left side.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents / adverse effects*
  • Humans
  • Leukemia, B-Cell / drug therapy*
  • Living Donors*
  • Lung Transplantation*
  • Male
  • Pleural Diseases / surgery*
  • Pulmonary Fibrosis / surgery*

Substances

  • Antineoplastic Agents